Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

Research Network

Collaboration Network

10 collaborators·27 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, Los Angeles

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David S Schrump, M.D.

National Cancer Institute (NCI)

Moderately Similar
21 trials

Shared therapeutic areas:

MelanomaMetastatic MelanomaNeoplasm Metastasis

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Agop Y. Bedikian, MD

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

National Cancer Institute (NCI)PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Lee Cranmer, M.D.

University of Arizona

Related
1 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

John Kirkwood, M.D.

University of Pittsburgh

Related
1 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Andres Forero, M.D.

University of Alabama at Birmingham

Related
2 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Steven J. O'Day, M.D.

Cancer Institute Medical Group, Inc.

Related
1 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Colin P. Curran, M.D.

Palmetto Hematology Oncology, P.C.

Related
1 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

MelanomaMetastatic Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Deborah E Citrin, M.D.

National Cancer Institute (NCI)

Related
13 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

William D Figg, Pharm.D.

National Cancer Institute (NCI)

Related
11 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00910650Phase 2PrincipalInvestigator

Study of Gene Modified Immune Cells in Patients With Advanced Melanoma

Metastatic Melanoma
Completed
NCT00099970Phase 2PrincipalInvestigator

Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy

MelanomaMetastases
Completed

All 2 trials loaded